BTA 0.00% 57.0¢ biota holdings limited

tamiflu epic fail

  1. 3,045 Posts.
    Well the news is getting out. Relenza will almost certainly benefit given this year will prompt replenishing anti viral supplies. Tamiflu has too many issues now and it's not only resistance. Main beneficiary will be Laninamivir.

    I've taken relenza twice over the years early into flu onset and I kid you not I felt better the very next day. I think Laninamivir may even be better but I don't have access to try and do t have the flu!

    The independent review directly challenges tamiflu efficacy.

    "Roche Flu Drug’s Effectiveness Is Unproven, Researchers Say"
    http://mobile.businessweek.com/news/2012-01-18/roche-flu-drug-s-effectiveness-is-unproven-researchers-say.html

    Review Challenges Tamiflu Efficacy
    http://abcnews.go.com/m/story?id=15381750
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.